Primary Cytotoxic T Cell Lymphomas Harbor Recurrent Targetable Alterations in the JAK-STAT Pathway
Demographics (3)
- COLLECTION_AGE - Age sample was collected (phv00492680.v1.p1)
- SEX - Biological sex (phv00492669.v1.p1)
- SEX - Subject sex (phv00492673.v1.p1)
Race and Ethnicity (1)
- RACE - Subject race (phv00492674.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00492677.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00492676.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00492668.v1.p1)
- GENOTYPING_CENTER - Center where samples were collected and sequencing data analyzed (phv00492683.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00492679.v1.p1)
- IS_TUMOR - Tumor status (phv00492678.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00492681.v1.p1)
- SAMPLE_ID - Sample ID (phv00492675.v1.p1)
- SAMPLE_ID - Sample ID (phv00492671.v1.p1)
- SEQUENCING_CENTER - Center where genetic sequencing was performed (phv00492684.v1.p1)
- SUBJECT_ID - Subject ID (phv00492667.v1.p1)
- SUBJECT_ID - Subject ID (phv00492672.v1.p1)
- SUBJECT_ID - Subject ID (phv00492670.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00492682.v1.p1)